Alnylam Pharmaceuticals
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
| Jobs: 71 - 80 of 81 |
Senior Manager, Medical Writing
Cambridge, Massachusetts
The Senior Manager, Medical Writing will collaborate with project teams on the development of clinical documents in accordance with all applicable regulations, Good Clinical Practices, and Standard Operating Procedures (SOPs) and will overs...
24d
Senior Associate Scientist, Oncology Research - In Vivo
Cambridge, Massachusetts
Overview: The Oncology Research group at Alnylam is seeking a highly motivated Senior Associate Scientist to join our growing interdisciplinary team aimed at developing RNAi therapeutics against cancer. The successful candidate will have ha...
24d
Cambridge, Massachusetts
Overview: The Director, Specification will be responsible for leading release and stability specifications development according to control strategy for Alnylam clinical programs. A successful candidate will be accountable for authoring and...
24d
Senior Director, Supply Chain Digital Strategy
Cambridge, Massachusetts
Overview The Senior Director, Supply Chain Digital Strategy will be a key business leader responsible for shaping and delivering the digital transformation vision for Alnylam's supply chain. This role will own the digital supply chain produ...
24d
Senior Manager, Program Management
Cambridge, Massachusetts
Overview At Alnylam, clinical-stage development programs are managed by a Global Program Leadership Team, led by a Program Leader and a Program Manager, responsible for harnessing cross-functional expertise to define the best scientific, cl...
24d
Principal Engineer, Manufacturing Technical Services
Cambridge, Massachusetts
Overview The Principal Engineer, Manufacturing Technical Services, will provide expert technical and GMP support for contract manufacturing organizations (CMOs) responsible for commercial drug product supply. This role will establish and ma...
24d
Cambridge, Massachusetts
Overview: Alnylam Pharmaceuticals is seeking a part-time Director of Alliance & Strategic Finance Optimization, who will serve as a strategic, enterprise-minded finance leader within the Alliance & Business Development (BD) Finance team. Th...
24d
Principal Associate Scientist, RNAi Discovery
Cambridge, Massachusetts
Overview The Research Department at Alnylam Pharmaceuticals is seeking a Principal Associate Scientist to join our High Throughput In Vitro team within the RNAi Discovery group. This dynamic, interdisciplinary team drives the discovery and ...
24d
Senior Director, Lab-to-Product Platform and Operations Technology
Cambridge, Massachusetts
Overview Alnylam is seeking a strategic and pragmatic technology leader to serve as Senior Director, Lab-to-Product Platform & Operations Technology, a role that owns the core digital platforms, services, lab computing environment, and oper...
24d
Cambridge, Massachusetts
Overview The Manager, Clinical Operations is responsible for the execution of study-level activities including but not limited to creating and updating trial-specific documents, vendor oversight & delivery, compound training and country and...
24d